9/17/2026 Daily Recap: The Bulls second wind? - NAAIM came in at 72 today so we have some money on the sidelines if this is going to grow some legs. - $MAGS closing right into all time highs, this group looks like it can start to lead from here. - $ARKG incredible trend continues. $TXG $TWST $HG $MRNA $TEM - Refiners non stop daily highs $VLO $DINO $PSX $MPC. Select shippers doing the same $ECO $TNK $INSW $STNG $FRO - Semiconductors with some fight. $SMTC $QRVO $AMD $INTC. - Memory names find a bid along the 50sma. $MU $SNDK. - Software names shaping up well $PLTR $CRM $TEAM $NOW. - $DELL $HPE $HPQ still with plenty of strength! - Cyber names gap down but find a bid back into new highs. $CRWD $OKTA $PANW $NET $RBRK - One day at a time but you have to be encouraged by the resilience of this market. - In an ideal world this chop ends soon, but before jumping for joy I still need to find myself in more names.

everyone seems to calculate tokens per second window differently A. time from request start to response end B. time from first token coming back to end of response i think it should be A (so it ecompasses TTFT), wdyt?

100% AFFINITY (without wex or gore) 86% WITHOUT AGITATOR 100% MAX MIGHT UPTIME VIA SECOND WIND FREE ZOH REGEN WITH MEDICINE 3 AND RECOVERY 3 GOOD SHARPNESS AND DAMAGE MAX OUT BURST THIS IS IT HOLYYYSHIIIIIT

more on Thursday’s Custom Pairs update: we've already seen a few cases where an established memecoin that's been stagnant for a while gets a second wind thanks to new coins being paired with it we’ve seen this play out for years: a new token launches, defines a meta, only to slow bleed once all catalysts are exhausted. now, custom pairs are a second chance, and in some cases, a new life. furthermore, if the token spawns a small ecosystem of paired tokens, its vampability decreases significantly; vamping an ecosystem of tokens which all contribute to the main runner is much harder than a strong token on its own I look forward to seeing this play out on a larger scale!

ROSIE CAN'T QUIT TALKING ABOUT TRUMP The boys of @lfs6b have some thoughts after @BeniRaeHarmony reports Rosie O'Donnell declared she's “refamous” and credited her feud with President Trump for giving her a second wind. “She just wants attention... She’s just obsessed.” @slickricksports @damonroberts

Elon Musk unveiled the Tesla Cybertruck in November 2019 and it became the most famous product launch failure in automotive history. Because the "unbreakable" windows shattered on live television in front of the entire world. Franz von Holzhausen, Tesla's head of design, was supposed to throw a metal ball at the driver window to demonstrate the armored glass. In rehearsals it worked perfectly. The glass held. The demonstration was supposed to be the dramatic highlight of the presentation. On stage Franz threw the ball. The glass shattered into a spiderweb of cracks. The audience gasped. Elon stared at the window. He said "oh my god." Then he told Franz to try the rear window. Franz threw the ball again. The second window also cracked. Elon stood on stage for the remaining 15 minutes of the presentation in front of a truck with two shattered windows. He did not leave the stage. He did not cut the presentation short. He continued presenting features and specs as if the most embarrassing product demo in Tesla's history was not sitting behind him in full view of every camera in the room. The stock dropped 6% the next day. The internet produced a million memes. Every automotive journalist wrote that the Cybertruck was dead on arrival. Then Elon tweeted the behind the scenes video of the rehearsal where the glass held perfectly and implied that the stage demo stress tested the glass beyond the rehearsal conditions. Within a week the Cybertruck had received over 250,000 pre orders. More than any truck launch in history. The broken windows generated more attention than a perfect demo ever could have. The failure became the marketing. The man who stood on stage in front of his most public failure and refused to flinch turned embarrassment into a quarter million orders.

Nebius $NBIS is outperforming CoreWeave $CRWV by nearly 8X in 2026, despite CoreWeave generating 5X more revenue – so, what gives? Clearly something is happening beyond the income statement. This week’s free newsletter looks more closely at two of the fastest-growing AI infrastructure companies on the market, including what could give CoreWeave a second wind. Link in bio.

im going to let sf men in on a crazy secret, and if you follow these instructions exactly, you'll be able to date any girl you want 1. most guys just dont have the balls to talk to women in public 2. if you have the confidence to approach a woman in public, you're disrupting the normal daily interaction, and you have a 30 second window in space and time to connect with this girl who is standing in front of you 3. if you are a base level attractive and some combination of enjoyable to be around, smart, and high status, almost any girl in sf will give you a shot 4. most women in sf are desperately seeking a partner, so we're in a men's market

Forget killing cancer cells. South Korea just figured out how to talk them back into being normal. Scientists at KAIST in Daejeon have done something the world has been chasing for decades. They found a molecular switch that flips cancer cells back into healthy cells. No chemo. No radiation. No destroying anything. Just… reversal. Professor Kwang-Hyun Cho and his team caught cancer in the act. That tiny window where a normal cell is on the edge of turning malignant but hasn't fully crossed over yet. They call it the "critical transition" — the same kind of jump that happens when water hits 100°C and becomes steam. In that split-second window, the cell is unstable. Normal and cancerous at the same time. And that's exactly where they hit the switch. In colon cancer trials, they targeted three master genes — MYB, HDAC2, and FOXA2 — and the cancer cells didn't die. They went back to being healthy intestinal cells. Like nothing ever happened. The team built a digital twin of the gene network to map every move a cell makes on its way to becoming cancerous. Then they reverse-engineered the path home. Their paper landed in Advanced Science, published by Wiley. It's still early. Lab trials and mice. Human treatment is years away. But the idea of curing cancer without killing a single cell is no longer science fiction. Source: KAIST (Korea Advanced Institute of Science and Technology), published in Advanced Science journal